Literature DB >> 2289976

Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: II. Electron microscopic immunocytochemical evidence of GABAergic control over the projection from the periaqueductal gray to the nucleus raphe magnus in the rat.

D B Reichling1, A I Basbaum.   

Abstract

Pharmacological, physiological, and behavioral studies suggest that inhibitory GABAergic neurons influence the projection from the midbrain periaqueductal gray matter to the medullary nucleus raphe magnus. The present study used electron microscopic immunocytochemical techniques to examine the morphology and synaptic relationships of GABA-immunoreactive terminals in the ventrolateral periaqueductal gray. These putative GABAergic terminals comprise almost 40% of all axon terminals in the periaqueductal gray. GABA-immunoreactive terminals contain small, clear, pleomorphic or round, vesicles, and 46% also contain some dense-cored vesicles. In some experiments we also used a colloidal gold-conjugated retrograde tracer to label periaqueductal gray neurons that project to the nucleus raphe magnus. About half of the synaptic inputs onto the cell bodies and proximal dendrites of retrogradely labeled neurons are GABA-immunoreactive; these putative GABAergic synapses, which directly control activity in neurons projecting from the periaqueductal gray to the nucleus raphe magnus, might mediate the antinociception-related effects of exogenous GABAA receptor ligands.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289976     DOI: 10.1002/cne.903020214

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  16 in total

1.  GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.

Authors:  Grace Lee; Stephen C Gammie
Journal:  Behav Brain Res       Date:  2010-05-08       Impact factor: 3.332

2.  Local GABAergic modulation of the activity of serotoninergic neurons in the nucleus raphe magnus.

Authors:  A N Inyushkin; N A Merkulova; A O Orlova; E M Inyushkina
Journal:  Neurosci Behav Physiol       Date:  2010-08-03

3.  A comparative study of excitatory and inhibitory amino acids in three different brainstem nuclei.

Authors:  Waleed M Renno; Moussa Alkhalaf; Alyaa Mousa; Reem A Kanaan
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

4.  Mechanism Underlying the Analgesic Effect Exerted by Endomorphin-1 in the rat Ventrolateral Periaqueductal Gray.

Authors:  Tao Chen; Jing Li; Ban Feng; Rui Hui; Yu-Lin Dong; Fu-Quan Huo; Ting Zhang; Jun-Bin Yin; Jian-Qing Du; Yun-Qing Li
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

5.  Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.

Authors:  H-T Liao; H-J Lee; Y-C Ho; L-C Chiou
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

6.  Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.

Authors:  Benjamin K Lau; Bryony L Winters; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

7.  Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a mu-opioid.

Authors:  L C Chiou; L Y Huang
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

8.  Analgesia induced by localized injection of opiate peptides into the brain of infant rats.

Authors:  G A Barr; S Wang
Journal:  Eur J Pain       Date:  2012-12-03       Impact factor: 3.931

9.  Contribution of dopamine receptors to periaqueductal gray-mediated antinociception.

Authors:  Paul J Meyer; Michael M Morgan; Laura B Kozell; Susan L Ingram
Journal:  Psychopharmacology (Berl)       Date:  2009-02-19       Impact factor: 4.530

10.  Release of endogenous amino acids from the hippocampus and brain stem from developing and adult mice in ischemia.

Authors:  Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2009-04-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.